Biovian

    OverviewSuggest Edit

    Biovian is a biopharmaceutical contract development and manufacturing company. It offers virus production for gene therapy and vaccines, microbial production of recombinant proteins and plasmid DNA, process development and formulation, analytical quality control, cell and virus bank preparation, and other services.
    TypePrivate
    Founded2003
    HQTurku, FI
    Websitebiovian.com

    Latest Updates

    Employees (est.) (Jun 2021)79(+4%)
    Cybersecurity ratingAMore

    Biovian Office Locations

    Biovian has an office in Turku
    Turku, FI (HQ)
    Tykistökatu 6
    Show all (1)

    Biovian Financials and Metrics

    Summary Metrics

    Founding Date

    2003

    Biovian Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    97/100

    SecurityScorecard logo

    Biovian Online and Social Media Presence

    Embed Graph

    Biovian News and Updates

    Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate

    STOCKHOLM, Dec. 31, 2020 /PRNewswire/ -- Eurocine Vaccines AB ("Eurocine Vaccines" or the "Company") has today selected Biovian Oy, Turku, Finland, ("Biovian") as the contract developer for the Company's vaccine candidate against chlamydia. Biovian, which is an internationally recognized...

    Biovian Blogs

    Lokon Pharma AB signs an agreement with Biovian

    Lokon Pharma AB, a company developing next-generation cancer therapeutics, has selected Biovian Oy as a CDMO partner for GMP manufacturing of LOAd703 for a pivotal randomized study. The uniquely engineered LOAd703 oncolytic virus is currently …

    GEN Magazine – Smooth Collaboration Between CDMOs and Tech Providers Boosts AAV Manufacturing Efficiency.

    GEN, one of the biggest magazines in the field of genetic engineering and biotechnology, discussed with four experts how the relationship between a CDMO and a technology provider can accelerate the transition from academia to …

    Viral Vector and gene therapy basics summarized

    Here we present some basic concepts of Viral Vectors used in gene therapy applications with special focus on AAV and Adenovirus vectors. Please proceed to this page if you are looking for information about our …

    Eija’s first week at Biovian – and how it all happened

    Announcements about job openings have been frequent at Biovian, since the company is growing steadily. Thus, several persons have been hired during the last few months. We asked Eija Martikkala, one of our newest colleagues, …

    Tenboron Ltd signs an agreement with Biovian for GMP contract manufacturing of a novel boron carrier for treating solid tumors

    Tenboron Ltd, the developer of a novel boron carrier for use in Boron Neutron Capture Therapy (BNCT), has selected Biovian Oy as a CDMO partner for GMP manufacturing of their drug candidate for phase I …

    The whys and the whats of GMP production of biopharmaceuticals

    What changes when a drug candidate moves from the research stage to GMP production – and why? Why’d you have to go and make things so complicated? This chorus of the pop-rock song, Complicated, may …
    Show more

    Biovian Frequently Asked Questions

    • When was Biovian founded?

      Biovian was founded in 2003.

    • How many employees does Biovian have?

      Biovian has 79 employees.

    • Who are Biovian competitors?

      Competitors of Biovian include TFS, Comac Medical and Cyprotex.

    • Where is Biovian headquarters?

      Biovian headquarters is located at Tykistökatu 6, Turku.

    • Where are Biovian offices?

      Biovian has an office in Turku.

    • How many offices does Biovian have?

      Biovian has 1 office.